PerkinElmer is targeting acquisitions and additional alliances in 2006 as it places greater emphasis on its health sciences operations and looks to expand its growth platforms, company officials recently said in a conference call.

Specifically, company officials said the firm will expand its drug-discovery tool portfolio "to include next-generation proteomics diagnostics," including reagents for biomarker discovery.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Wired reports that 23andMe is trying to bolster its outside collaborations.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.